|
 Viewing Category

Entries for the 'Pharmacetical Drug Litigation' Category

Jon Gelman Listed in Best Lawyers in America 2018

Jon Gelman has been listed again to Best Lawyers in America®. This recognition has been bestowed upon him for almost 2 decades. 

In December 2011, Tekturna® manufacturer Novartis announced its decision to terminate the clinical ALTITUDE study of the blood pressure drug based on the recommendation of the independent Data Monitoring Committee (DMC) overseeing the clinical trial study. 

 Following a November 2011 warning issued by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) decided to reevaluate the safety of Pradaxa®. 

FDA Votes to Restrict Avandia Due to Risks

Jon L Gelman is investigating cases involving individuals who have suffered a heart attack, ischemic stroke or other cardiac condition while taking Avandia for diabetes.

Jon Gelman is investigating cases involving infant drugs manufactured by pharmaceutical company McNeil Consumer Healthcare including include certain liquid infant’s and children’s Tylenol®, Motrin®, Zyrtec®, and Benadryl® products.

Jon Gelman is investigating cases involving Paxil users who have a child who suffered birth malformations after being exposed to Paxil within any trimester of pregnancy. Paxil and Paxil CR® are antidepressants manufactured by the pharmaceutical company GlaxoSmithKline.

FDA Requires  Botox®  Maker to Notify of Potential Adverse Effects

 FDA requires manufacturer of Botox® to post warning on its product of potential adverse reactions.

Medtronic Paradigm® Quick-set® Infusion Sets Recalled Due to Potential Injuries

On July 10, 2009, Medtronic, Inc., announced a defect in the Paradigm® Quick-Set® Infusion Sets. The company identified a potentially high rate of failure of the system to function properly and deliver medication to the patient in an accurate manner through the pump.

Levaquin®  Treatment Reactions  Causes FDA To Require Warning

In July 2008, the FDA announced a mandatory black box warning label for fluoroquinolone drugs that highlights and strengthens the warning for increased risk of tendonitis and tendon rupture

FDA Alerts Consumers Concering Zicam®

Jon L. Gelman LLC is investigating cases involving individuals who have suffered the loss of taste and smell (anosmia) after using Zicam®. Zicam® is an over-the-counter nasal spray used to relieve the symptoms associated with the common cold and flu and is manufactured by Matrixx Initiatives. Matrixx manufactures a range of products under the Zicam® name, but the name Zicam® is generally used to refer to its over-the-counter nasal zinc solution spray.  

Raptiva® Withdrawn From Market for High Risk of Fatal Brain Disease

We are investigating cases in which Raptiva® users have experienced neurological changes including unusual weakness, loss of coordination and changes in vision.

On April 8, 2009, the drug manufacturer Genentech announced a phased withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. market.
 

The Compensability of a Swine Flu Pandemic

The US Centers for Disease Control (CDC) has issued an alert for the spread of human swine flu virus. Employers and employees will now need to be alerted to preparations and the reactions that may occur.

Hydroxycut® Products Withdrawn From Market After FDA Consumer Advisory Warning
Jon L. Gelman  is investigating potential cases involving users of Hydroxycut® products who have experienced health problems that may include Rha...
Grease Removers Recalled by Fantastic Distributors Due to Chemical Burn Hazard

 The U.S. Consumer Product Safety Commission, in cooperation with the firm named below, today announced a voluntary recall of "Bagi Shumanit" Super Cold Grease Removers. Consumers should stop using recalled products immediately unless otherwise instructed.

Infant Death Prompts Recall to Repair 985,000 Delta Enterprise Drop Side Cribs

The U.S. Consumer Product Safety Commission (CPSC), in cooperation with Delta Enterprise Corp., of New York, New York., announced the recall to replace missing safety pegs involving 985,000 drop side cribs. Failure to use or install safety pegs can cause an entrapment and suffocation risk to infants and toddlers.
 

Fosamax Adverse Reactions

Fosamax® (alendronate sodium tablets and oral solution) is a bisphosphonate manufactured by Merck, that is marketed, advertised, distributed and sold for the treatment of osteoporosis and Paget’s Disease. It has additionally been prescribed for off label uses such as bone cancers. Fosamax® tablets were approved by the FDA on September 29, 1995, while the oral solution was approved on September 17, 2003.

NuvaRing® Safety Labeling Changes

NuvaRing® is a vaginal ring contraceptive medication that was approved by the FDA in October 2001. The drug is manufactured by Organon USA, Inc., based in New Jersey, which was acquired by Schering-Plough Corporation in 2007. Since its initial FDA approval and use on the market, NuvaRing® has been linked to serious venous thromboembolic events including blood clots, pulmonary embolism, stroke and myocardial infarction, or heart attack.
 

Cephalon Changes Label of Provigil for Additional Side Effects

PROVIGIL is a medication that has the active ingredient of Modanifil and is used to treat excessive sleepiness caused by certain sleep disorders. These sleep disorders are narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. In addition to its wakefulness-promoting effects, PROVIGIL produces psychoactive and euphoric effects, alterations in mood, perception, thinking, and feelings typical of other central nervous system stimulants.

Medtronic Announces Defect in Sprint Fidelis Defibrillation Leads

On October 14, 2007, Medtronic, the nation's largest heart implant device manufacturer, announced a defect in the critical electrical "lead" component of its heart defibrillator. The New York Times reported on October 15, 2007, that the defect in this electrical wire, called the Sprint Fidelis, has resulted in hundreds of malfunctions and may have

Recall Of Certain Composix® Kugel® Mesh Patches Used In Hernia Repair

Specific lot numbers of the Composix® Kugel® Mesh Patches, used to repair ventral (incisional) hernias caused by thinning and stretching of scar tissue post-surgery, were recently recalled by manufacturer Davol, Inc., a subsidiary of C.R. Bard, Inc. The recall occurred after it was discovered that the "memory recoil ring," which opens the patch, can break under the stress of placement in the intra-abdominal space. This can lead to serious intestinal conditions such as bowel perforations and/or chronic intestinal fistulae (abnormal connections or passageways between the intestines and other organs).
 

Page 1 of 2First   Previous   [1]  2  Next   Last   
Copyright 2018 by Jon Gelman, LLC - Attorney at Law. All rights reserved.   |  Privacy Statement  |  Terms Of Use